Alienor Berges has over 10 years of experience in Clinical Pharmacology applied to pharmaceutical research and development across various disease areas, including small and large molecules. She has worked in several large pharmaceutical companies.
Currently, she is a Senior Clinical Pharmacologist in Quantitative Clinical Pharmacology at AstraZeneca, UK, where she is contributing to the clinical development and registration of new oncology drugs. In this role she is responsible for contributions to program plans, trial protocols, analysis plans, study reports and regulatory submissions.
With a Pharmacy diploma from Paris University and a specialization in statistical modeling and simulation, her focus is to promote and apply innovative methods to maximise data use, trial efficiency and support investment decisions in drug development.